Allergan showing notable strength after-hours, currently trading at $165 vs. $142 close; strength is being attributed to M&A / activist speculation
The headlines suggest Bill Ackman and Valeant (VRX) could do a deal with Allergan (AGN) -- according to CNBC citing Dow Jones in a tweet.